Decision analysis for transplant candidates with primary myelofibrosis in the ruxolitinib era.

Autor: Okada Y; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama., Nakasone H; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan; Division of Emerging Medicine for Integrated Therapeutics (EMIT), Center for Molecular Medicine, Jichi Medical University, Shimotsuke., Kawamura S; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama., Takano K; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama., Yoshimura K; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama., Tamaki M; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama., Matsuoka A; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama., Ishikawa T; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama., Meno T; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama., Nakamura Y; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama., Kawamura M; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama., Takeshita J; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama., Yoshino N; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama., Misaki Y; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama., Kusuda M; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama., Tanihara A; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama., Kimura SI; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama., Kako S; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama., Kanda Y; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama. ycanda-tky@umin.ac.jp.

Publikováno v: Haematologica [Haematologica] 2024 Nov 01; Vol. 109 (11), pp. 3593-3601. Date of Electronic Publication: 2024 Nov 01.

Phase-Coherent Dynamics of a Superconducting Flux Qubit with Capacitive-Bias Readout

Autor: Deppe, F., Mariantoni, M., Menzel, E. P., Saito, S., Kakuyanagi, K., Tanaka, H., Meno, T., Semba, K., Takayanagi, H., Gross, R.

Publikováno v: Phys. Rev. B 76, 214503 (2007)

We present a systematic study of the phase-coherent dynamics of a superconducting three-Josephson-junction flux qubit. The qubit state is detected with the integrated-pulse method, which is a variant of the pulsed switching DC SQUID method. In this s

Externí odkaz: http://arxiv.org/abs/0710.4455

Dephasing of a superconducting flux qubit

Autor: Kakuyanagi, K., Meno, T., Saito, S., Nakano, H., Semba, K., Takayanagi, H., Deppe, F., Shnirman, A.

In order to gain a better understanding of the origin of decoherence in superconducting flux qubits, we have measured the magnetic field dependence of the characteristic energy relaxation time ($T_1$) and echo phase relaxation time ($T_2^{\rm echo}$)

Externí odkaz: http://arxiv.org/abs/cond-mat/0609564

Vacuum Rabi oscillations in a macroscopic superconducting qubit LC oscillator system

Autor: Johansson, J., Saito, S., Meno, T., Nakano, H., Ueda, M., Semba, K., Takayanagi, H.

We have observed the coherent exchange of a single energy quantum between a flux qubit and a superconducting LC circuit acting as a quantum harmonic oscillator. The exchange of an energy quantum is known as the vacuum Rabi oscillations: the qubit is

Externí odkaz: http://arxiv.org/abs/cond-mat/0510457

Clinical impact of a change in antibiotics or the addition of glycopeptide antibiotics for persistent febrile neutropenia after autologous stem cell transplantation.

Autor: Yoshino N; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan., Kimura SI; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan., Kawamura K; Division of Clinical Laboratory Medicine, Department of Multidisciplinary Internal Medicine, Faculty of Medicine, Tottori University, Yonago, Japan., Nakata Y; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan., Matsuoka A; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan., Ishikawa T; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan., Meno T; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan., Nakamura Y; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan., Kawamura M; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan., Kawamura S; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan., Takeshita J; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan., Misaki Y; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan., Yoshimura K; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan., Gomyo A; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan., Okada Y; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan., Tamaki M; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan., Kusuda M; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan., Kameda K; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan., Akahoshi Y; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan., Sato M; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan., Tanihara A; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan., Nakasone H; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan., Kako S; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan., Kanda Y; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan; Division of Hematology, Department of Medicine, Jichi Medical University, Shimotsuke, Japan. Electronic address: ycanda-tky@umin.ac.jp.

Publikováno v: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy [J Infect Chemother] 2024 Jun 24. Date of Electronic Publication: 2024 Jun 24.